Russia’s deputy FM says the talks could lead to higher-level negotiations.
By Dave DeCamp, AntiWar.com
The US and Russia will hold talks on the last nuclear arms control treaty that remains between the powers, the New START, from November 29 to December 6 in Cairo, Egypt.

The dates were announced by Russian Deputy Foreign Minister Sergey Ryabkov, who suggested Friday that the talks could lead to higher-level negotiations with the US. The State Department said earlier in November that the US and Russia had agreed to hold talks under the bilateral consultative commission (BCC), an implementation body established by the New START.
The New START treaty puts limits on the deployment of warheads, missiles, and bombers and includes an inspection regime. But according to the State Department, the inspections were paused in March 2020 due to Covid-19 and haven’t been resumed since.
The talks in Cairo are expected to be focused on the resumption of inspections. The New START expires in 2026, and there’s currently no agreement for a replacement or any further arms control treaties between the US and Russia.
Recent Posts
Washington, DC, Residents Protest Against Trump
September 7, 2025
Take Action Now Several thousand protesters march to oppose Trump’s troop deployment Justice Department data shows violent crime at 30-year low…
‘Shameful Assault on Human Rights’: Trump Sanctions Palestinian Orgs That Called for UN to Investigate Israeli War Crimes
September 6, 2025
Take Action Now The former executive director of Human Rights Watch said Trump’s “answer to Israeli atrocities is to censor reporting on…
Hegseth Doesn’t Rule Out Regime Change In Venezuela, Suggests More U.S. Strikes On Boats Are Coming
September 5, 2025
Take Action Now When asked if the goal was regime change in Venezuela, Hegseth said that was a “presidential decision” and added that “we’re prepared…
Secretary Kennedy Doesn’t Care About Long COVID Patients
September 5, 2025
Take Action Now Reckless funding cuts have dealt a significant blow to ongoing research, derailing NIH-funded clinical trials on antivirals and…